BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
21 results:

  • 1. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
    Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
    Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of p300 increases cytotoxicity of cisplatin in pancreatic cancer cells.
    Bugbee T; Gathoni M; Payne C; Blubaugh M; Matlock K; Wixson T; Lu A; Stancic S; Chung PA; Palinski R; Wallace N
    Gene; 2023 Dec; 888():147762. PubMed ID: 37666373
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
    Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
    Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
    He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
    Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer.
    Ono H; Kato T; Murase Y; Nakamura Y; Ishikawa Y; Watanabe S; Akahoshi K; Ogura T; Ogawa K; Ban D; Kudo A; Akiyama Y; Tanaka S; Ito H; Tanabe M
    Sci Rep; 2021 May; 11(1):10078. PubMed ID: 33980911
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
    Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
    Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]    [Full Text] [Related]  

  • 8. A Novel E2F1-ep300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in pancreatic cancer Cells Carrying Oncogenic KRAS.
    Ropolo A; Catrinacio C; Renna FJ; Boggio V; Orquera T; Gonzalez CD; Vaccaro MI
    Front Endocrinol (Lausanne); 2020; 11():411. PubMed ID: 32655498
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.
    McGinn O; Gupta VK; Dauer P; Arora N; Sharma N; Nomura A; Dudeja V; Saluja A; Banerjee S
    Sci Rep; 2017 Aug; 7(1):7872. PubMed ID: 28801636
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer Stem-like Properties in Colorectal cancer Cells with Low Proteasome Activity.
    Munakata K; Uemura M; Tanaka S; Kawai K; Kitahara T; Miyo M; Kano Y; Nishikawa S; Fukusumi T; Takahashi Y; Hata T; Nishimura J; Takemasa I; Mizushima T; Ikenaga M; Kato T; Murata K; Carethers JM; Yamamoto H; Doki Y; Mori M
    Clin Cancer Res; 2016 Nov; 22(21):5277-5286. PubMed ID: 27166395
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.
    Lin RX; Gong LL; Fan LM; Zhao ZK; Yang SL
    Int J Clin Exp Pathol; 2015; 8(2):1427-34. PubMed ID: 25973027
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LB-1 Exerts Antitumor Activity in pancreatic cancer by Inhibiting HIF-1α and Stat3 Signaling.
    Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
    J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.
    Bhattacharjee V; Zhou Y; Yen TJ
    Cell Cycle; 2014; 13(24):3839-56. PubMed ID: 25558828
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
    Chen H; Guan Y; Yuan G; Zhang Q; Jing N
    Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
    Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
    Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pancreatic head resection with segmental duodenectomy: safety and long-term results.
    Nakao A; Fernández-Cruz L
    Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.